ALERE INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 10 rows in 2016. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-12-30: Reporting owner Pelossof Avi; Form 4; Security Employee Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-12-30: Reporting owner Pelossof Avi; Form 4; Security Employee Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-12-30: Reporting owner Pelossof Avi; Form 4; Security Employee Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-12-15: Reporting owner HEMPEL PAUL T; Form 4; Security Employee Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-12-30 | Pelossof Avi Officer (GlobalPres, Infectious Disease) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 9,668 owned after | $38.70 exercise price | 2017-01-04 | |
| 2016-12-30 | Pelossof Avi Officer (GlobalPres, Infectious Disease) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,668 0 owned after | $38.70 exercise price | 2017-01-04 | |
| 2016-12-30 | Pelossof Avi Officer (GlobalPres, Infectious Disease) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,332 0 owned after | $38.70 exercise price | 2017-01-04 | |
| 2016-12-15 | HEMPEL PAUL T Officer (Sr VP, LD & Legal Affairs) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,355 12,355 owned after | $38.10 exercise price | 2006-12-19 | |
| 2016-10-14 | Chiniara Ellen Officer (GC, Chief Ethics Officer&Sec) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,500 7,096 owned after | $37.74 exercise price | 2016-10-18 | |
| 2016-10-14 | Chiniara Ellen Officer (GC, Chief Ethics Officer&Sec) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,096 0 owned after | $37.74 exercise price | 2016-10-18 | |
| 2016-10-14 | Chiniara Ellen Officer (GC, Chief Ethics Officer&Sec) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,404 0 owned after | $37.74 exercise price | 2016-10-18 | |
| 2016-10-14 | Chiniara Ellen Officer (GC, Chief Ethics Officer&Sec) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 0 owned after | $37.74 exercise price | 2016-10-18 | |
| 2016-10-03 | Gladwell Mark Officer (Senior VP, Global Operations) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 0 owned after | $34.40 exercise price | 2016-10-05 | |
| 2016-02-01 | Guerdan Melissa Officer (SVP, Global Quality & Reg.) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +2,500 4,415 owned after | $33.73 exercise price | 2016-02-03 |